Correlation Between Atlas Copco and Ascelia Pharma
Can any of the company-specific risk be diversified away by investing in both Atlas Copco and Ascelia Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Atlas Copco and Ascelia Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Atlas Copco AB and Ascelia Pharma AB, you can compare the effects of market volatilities on Atlas Copco and Ascelia Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Atlas Copco with a short position of Ascelia Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Atlas Copco and Ascelia Pharma.
Diversification Opportunities for Atlas Copco and Ascelia Pharma
-0.38 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Atlas and Ascelia is -0.38. Overlapping area represents the amount of risk that can be diversified away by holding Atlas Copco AB and Ascelia Pharma AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ascelia Pharma AB and Atlas Copco is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Atlas Copco AB are associated (or correlated) with Ascelia Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ascelia Pharma AB has no effect on the direction of Atlas Copco i.e., Atlas Copco and Ascelia Pharma go up and down completely randomly.
Pair Corralation between Atlas Copco and Ascelia Pharma
Assuming the 90 days trading horizon Atlas Copco AB is expected to under-perform the Ascelia Pharma. But the stock apears to be less risky and, when comparing its historical volatility, Atlas Copco AB is 3.0 times less risky than Ascelia Pharma. The stock trades about -0.1 of its potential returns per unit of risk. The Ascelia Pharma AB is currently generating about 0.23 of returns per unit of risk over similar time horizon. If you would invest 265.00 in Ascelia Pharma AB on September 12, 2024 and sell it today you would earn a total of 51.00 from holding Ascelia Pharma AB or generate 19.25% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Atlas Copco AB vs. Ascelia Pharma AB
Performance |
| Timeline |
| Atlas Copco AB |
| Ascelia Pharma AB |
Atlas Copco and Ascelia Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Atlas Copco and Ascelia Pharma
The main advantage of trading using opposite Atlas Copco and Ascelia Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Atlas Copco position performs unexpectedly, Ascelia Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ascelia Pharma will offset losses from the drop in Ascelia Pharma's long position.| Atlas Copco vs. Sandvik AB | Atlas Copco vs. ASSA ABLOY AB | Atlas Copco vs. Alfa Laval AB | Atlas Copco vs. AB SKF |
| Ascelia Pharma vs. Hansa Biopharma AB | Ascelia Pharma vs. Cantargia AB | Ascelia Pharma vs. Saniona AB | Ascelia Pharma vs. BioArctic AB |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |